CA Stock MarketDetailed Quotes
IPCI.H IntelliPharmaCeutics International Inc(Delisted)
- 0.080
- 0.0000.00%
15min DelayMarket Closed Mar 5 10:01 ET
2.65MMarket Cap-0.66P/E (TTM)
0.000High0.000Low0Volume0.000Open0.080Pre Close0.00Turnover0.00052wk High0.00%Turnover Ratio33.09MShares0.00052wk Low-0.122EPS TTM2.60MFloat Cap0.000Historical HighLossP/E (Static)32.51MShs Float0.000Historical Low-0.121EPS LYR0.00%Amplitude--Dividend TTM-0.15P/B1Lot Size--Div YieldTTM
IntelliPharmaCeutics International Inc(Delisted) Key Stats
Quarterly+Annual
YOY
| (Q3)Aug 31, 2023 | (Q2)May 31, 2023 | (Q1)Feb 28, 2023 | (FY)Nov 30, 2022 | (Q4)Nov 30, 2022 | (Q3)Aug 31, 2022 | (Q2)May 31, 2022 | (Q1)Feb 28, 2022 | (FY)Nov 30, 2021 | (Q4)Nov 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 260.38%68.72K | 480.2K | 291.25%326.34K | 65.73K | 29.68K | 19.07K | 0 | 83.41K | 0 | 0 |
| Operating revenue | 260.38%68.72K | --480.2K | 391.24%326.34K | --48.75K | --12.7K | --19.07K | --0 | --66.43K | --0 | --0 |
| Cost of revenue | 17.43K | 0 | ||||||||
| Gross profit | 168.99%51.29K | 19.07K | ||||||||
| Operating expense | 364.35%1.79M | -59.14%511.56K | -26.69%627.74K | -30.12%2.92M | -36.52%887.09K | -64.45%385.25K | 25.15%1.25M | 9.10%856.33K | -31.36%4.17M | -20.68%1.4M |
| Selling and administrative expenses | 166.21%193.53K | -61.60%93.5K | -46.78%138.84K | -55.10%561.05K | 6.01%348.99K | -199.01%-292.3K | -46.27%243.5K | 51.62%260.86K | -41.81%1.25M | -41.51%329.19K |
| Research and development costs | 148.34%1.55M | -60.55%377.51K | -17.62%448.17K | -19.26%2.15M | -51.49%486.48K | -13.43%626.07K | 98.65%956.85K | -0.64%543.99K | -24.31%2.66M | -8.07%1M |
| Depreciation amortization depletion | -21.08%40.63K | -21.24%40.55K | -20.86%40.74K | -21.21%206.06K | -21.04%51.62K | -21.26%51.48K | -21.26%51.48K | -21.27%51.48K | -37.04%261.53K | -39.46%65.38K |
| -Depreciation and amortization | -21.08%40.63K | -21.24%40.55K | -20.86%40.74K | -21.21%206.06K | -21.04%51.62K | -21.26%51.48K | -21.26%51.48K | -21.27%51.48K | -37.04%261.53K | -39.46%65.38K |
| Operating profit | -374.52%-1.74M | 97.50%-31.36K | 61.00%-301.4K | 31.69%-2.85M | 67.11%-459.58K | 66.21%-366.18K | -38.04%-1.25M | 1.53%-772.92K | 10.80%-4.17M | 4.44%-1.4M |
| Net non-operating interest income (expenses) | -26.13%-66.89K | 29.37%-51.89K | 49.52%-50.76K | 46.91%-291.62K | 64.49%-64.56K | 75.04%-53.03K | 7.52%-73.47K | -33.02%-100.56K | 43.35%-549.3K | -120.87%-181.81K |
| Non-operating interest income | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Non-operating interest expense | 26.13%66.89K | -29.37%51.89K | -49.52%50.76K | -46.91%291.62K | -64.49%64.56K | -75.04%53.03K | -7.52%73.47K | 33.02%100.56K | -43.35%549.3K | 120.87%181.81K |
| Other net income (expenses) | -128.39%-34.97K | -93.99%29.12K | 52.26%-3.58K | 147.50%255.07K | 29.68%-345.25K | 285.31%123.17K | 3,587.64%484.64K | 88.30%-7.49K | -123.45%-536.97K | -1,002.27%-490.99K |
| Gain on sale of security | -128.39%-34.97K | 289.63%29.12K | 52.26%-3.58K | 1,037.61%210.63K | 369.08%110.31K | 285.31%123.17K | -10.51%-15.36K | 88.30%-7.49K | 86.67%-22.47K | 198.46%23.52K |
| Special income (charges) | --0 | --0 | ---- | 108.64%44.44K | 11.46%-455.57K | --0 | --500K | ---- | -1,136.69%-514.5K | -2,390.45%-514.5K |
| -Less:Impairment of capital assets | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --514.5K | ---- |
| -Gain on sale of property,plant,equipment | --0 | --0 | ---- | --44.44K | ---455.57K | --0 | --500K | ---- | --0 | --0 |
| Income before tax | -521.36%-1.84M | 93.56%-54.12K | 59.62%-355.74K | 45.11%-2.89M | 58.01%-869.39K | 76.58%-296.04K | 15.95%-840.65K | 4.72%-880.97K | -56.62%-5.26M | -30.27%-2.07M |
| Income tax | 104.67%5.34K | -447.78%-114.19K | ||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -521.36%-1.84M | 93.56%-54.12K | 59.62%-355.74K | 43.78%-2.89M | 55.28%-874.73K | 76.58%-296.04K | 15.95%-840.65K | 4.72%-880.97K | -51.73%-5.15M | -20.59%-1.96M |
| Net income continuous operations | -521.36%-1.84M | 93.56%-54.12K | 59.62%-355.74K | 43.78%-2.89M | 55.28%-874.73K | 76.58%-296.04K | 15.95%-840.65K | 4.72%-880.97K | -51.73%-5.15M | -20.59%-1.96M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -538.16%-1.89M | 93.56%-54.12K | 59.62%-355.74K | 43.78%-2.89M | 55.28%-874.73K | 76.58%-296.04K | 15.95%-840.65K | 4.72%-880.97K | -51.73%-5.15M | -20.59%-1.96M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -538.16%-1.89M | 93.56%-54.12K | 59.62%-355.74K | 43.78%-2.89M | 55.28%-874.73K | 76.58%-296.04K | 15.95%-840.65K | 4.72%-880.97K | -51.73%-5.15M | -20.59%-1.96M |
| Diluted earnings per share | -500.00%-0.06 | 93.33%-0.002 | 66.67%-0.01 | 47.06%-0.09 | 66.67%-0.02 | 75.00%-0.01 | 25.00%-0.03 | 25.00%-0.03 | -21.43%-0.17 | 0.00%-0.06 |
| Basic earnings per share | -500.00%-0.06 | 93.33%-0.002 | 66.67%-0.01 | 47.06%-0.09 | 66.67%-0.02 | 75.00%-0.01 | 25.00%-0.03 | 25.00%-0.03 | -21.43%-0.17 | 0.00%-0.06 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Price
% Chg
No Data